With new measures for increasing the availability and safety of veterinary medicines it should also enhance EU action against antimicrobial resistance. Regulation (EU) 2019/6 repealed Directive 2001/82/EC. Furthermore, it amended the provisions of Regulation (EU) 726/2004 relating to the authorisation and supervision of veterinary medicines, which currently governs the centralised marketing authorisation procedure for both human and veterinary medicines.

In accordance with Regulation (EU) 2019/6, the European Commission added two standalone GDP regulations to Eudralex Volume 4:

• Commission Implementing Regulation (EU) 2021/1248 on good distribution practice for veterinary medicinal products
• Commission Implementing Regulation (EU) 2021/1280 on good distribution practice for active substances used as starting materials in veterinary medicinal products

The documents are compiled analogously to the GDP guidelines for medicinal products for human use and their active substances. All documents can be found in Eudralex Volume 4.

Source:

EC: Eudralex Volume 4